by michael | Apr 6, 2017 | Taxotere
Thousands of cancer survivors along with Winter Park-based law firm, The Michael Brady Lynch Firm are teaming up to fight against Sanofi-Aventis, the manufacturer of the common chemotherapy drug, Taxotere. Sanofi knew Taxotere brought terrible side effects to cancer... by michael | Apr 4, 2017 | Taxotere
Taxotere manufacturer, Sanofi-Aventis knew that their chemotherapy drug could cause permanent hair loss back in the 1990s. The company disclosed to other countries this side effect, but they hid it from patients in the United States. Instead of protecting consumers,... by michael | Mar 30, 2017 | Taxotere
The U.S. Judicial Panel on Multidistrict Litigation (JPML) allowed claims revolving around the generic form of Taxotere (docetaxel) to be included in the current Taxotere MDL being tried in the Eastern District of Louisiana. Currently, there are almost 800 lawsuits... by michael | Mar 28, 2017 | Taxotere
Chemotherapy-induced hair loss (alopecia) is a side effect many breast cancer patients understand is a distinct possibility. However, they believe the alopecia only occurs during treatment. After chemotherapy and remission, survivors look forward to hair regrowth, a... by michael | Mar 23, 2017 | Taxotere
One in eight women will be diagnosed with breast cancer. This equates to almost 300,000 U.S. women every year. Almost 75% of these women will use Taxotere to battle their cancer. But, they were never told there is a chance that by using Taxotere, they could always... by michael | Apr 29, 2016 | Taxotere
One in eight women will receive the horrendous, life-crushing news that they have breast cancer. Almost 300,000 U.S. women every year are diagnosed with this frightening and awful disease. The biggest wish these women have is to beat cancer and get their life back....
Recent Comments